安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Gilead Sciences
Gilead Sciences, a biopharma company, achieves bold ambitions to help make the world a healthier place, leading in HIV, liver disease, cancer inflammation
- Gilead Sciences: Company
Learn about the biopharmaceutical company Gilead Sciences, including mission, vision, values, history, impact, leadership, therapeutic areas and other information
- Medicines - Gilead Sciences
Access the list of approved Gilead therapies across virology including HIV, liver disease including hepatitis and primary biliary cholangitis, oncology inflammation
- Careers at Gilead Sciences
Grow Your Career at Gilead With more than 18,000 employees spanning across 40+ countries on six continents, we have a global workforce dedicated to creating a better, healthier world for everyone Explore Opportunities
- Pursuing Advances in Research at Gilead Sciences
For more than 35 years, our scientific insights and bold ambitions for transforming the course of disease have guided Gilead researchers to achieve advancements in drug discovery that were once thought impossible – including cures
- Virology, Inflammation, Oncology Pipeline | Gilead
Through science and innovative partnerships, Gilead expands research and development programs in virology, oncology, inflammation Learn about our pipeline
- Yeztugo Lenacapavir Is Now the First and Only FDA Approved HIV . . .
FOSTER CITY, Calif --(BUSINESS WIRE)-- Gilead Sciences, Inc (Nasdaq: GILD) today announced that the U S Food and Drug Administration (FDA) has approved Yeztugo ® (lenacapavir)—the company’s injectable HIV-1 capsid inhibitor—as pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV in adults and adolescents weighing
- Newsroom | Gilead
This is our global website, intended for visitors seeking information on Gilead’s worldwide business Some content on this site is not intended for people outside the United States Visit our Global Operations page for links to our international corporate websites
|
|
|